EDGAR Filing Documents for 0001144204-13-003478

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]

SEC Accession No. 0001144204-13-003478

Filing Date

2013-01-22

Accepted

2013-01-22 16:52:43

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT NO. 2 TO F-1	v332606_f1a.htm	F-1/A	1923101
2	EXHIBIT 5.1	v332606_ex5-1.htm	EX-5.1	42342
3	EXHIBIT 23.1	v332606_ex23-1.htm	EX-23.1	2648
5	GRAPHIC	image_002.jpg	GRAPHIC	2701
6	GRAPHIC	tlogo.jpg	GRAPHIC	14866
7		filename7.htm	CORRESP	24641
	Complete submission text file	0001144204-13-003478.txt		2018244

Mailing Address C/O MARK COHEN, CHAIRMAN, PEARL COHEN 1500 BROADWAY, 12TH FLOOR NEW YORK NY 10036

Business Address 53 DAVIES STREET LONDON X0 W1K 5JH 646-878-0804

Morria Biopharmaceuticals PLC (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: F-1/A | Act: 33 | File No.: 333-185247 | Film No.: 13540833
SIC: 2834 Pharmaceutical Preparations